Interestingly, results show that high DIS3L2 gene expression correlates with poorer prognosis in patients with advanced CRC (stages III and IV) (cut-off value: 3.2 FPKM; p < 0.05, Fig. 1B). This evidence concerns the gene DIS3L2 and colorectal carcinoma.